Spare whole brain radiotherapy for lung cancer patients whose tumour has spread to the brain
Whole brain radiotherapy makes little or no difference to survival rates or quality of life in patients with non-small cell lung cancer (NSCLC) which has spread to the brain, say researchers.
Up to 30% of patients with NSCLC have the disease spread to the brain. They are typically treated with steroids and supportive care, such as pain relief, to control cancer symptoms. They may also be offered whole brain radiotherapy daily for one or two weeks to improve symptoms.
Around 45,000 people are diagnosed with lung cancer in the UK every year. An estimated 85% of cases are NSCLC.
To assess the benefit of this, the Cancer Research UK-funded team studied 538 patients from the UK and Australia. Half had whole...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests